Express Delivery
All orders are shipped with Econt
Cash on delivery
Reliable and convenient payment methods
Proven quality
Peptides Tested at Janoshik Labs
Express delivery in 1-3 business days.
Each peptide comes with bacteriostatic water.
Tirzepatide is a synthetic peptide composed of 39 amino acids. It is a dual agonist of GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptors. This combined activity distinguishes it from other incretin analogues that only affect the GLP-1 receptor.
It was initially developed for the treatment of type 2 diabetes mellitus, but clinical studies have described a pronounced effect on weight reduction. In research models, improved insulin sensitivity, blood sugar control, and a beneficial effect on metabolic and cardiovascular parameters have been observed.
Tirzepatide is being investigated for its possible effects on:
Blood sugar control – in research models, a reduction in HbA1c and glucose spikes has been observed.
Weight reduction – an effect on body fat loss and improvement in body composition has been described.
Metabolic health – an improvement in lipid profile and reduction in hepatic steatosis has been observed.
Cardiovascular function – in research settings, a decrease in blood pressure and triglycerides has been described.
Energy homeostasis – an effect related to increased fat oxidation and optimization of energy balance has been observed.
Tirzepatide has been studied in large clinical trials, where it has emerged as a strong incretin analogue with a wide range of benefits.
In patients with type 2 diabetes mellitus, the following have been reported:
- Reduction in HbA1c by up to 2%
- Weight loss of 10-15%
- Improvement in lipid profile and blood pressure
In people with obesity without diabetes, the following have been observed:
- Weight loss of up to 20% over 72 weeks
- Reduction in visceral fat
- Improvement in cardio-metabolic parameters
Scientific literature describes subcutaneous administration once weekly.
Standard doses: 2.5 mg - initial dose with gradual titration up to 5 mg weekly depending on tolerance and therapeutic effect.
For 5 mg + 2 ml bacteriostatic water:
Concentration = 2.5 mg/ml → 0.4 ml = 1 mg
Example values for 5 mg:
0.1 ml = 250μg
0.2 ml = 500μg
0.3 ml = 750μg
0.4 ml = 1 mg
0.5 ml = 1.25 mg
For 10 mg + 2 ml bacteriostatic water:
Concentration = 5 mg/ml → 0.2 ml = 1 mg
Example values for 10 mg:
0.1 ml = 500μg
0.2 ml = 1 mg
0.3 ml = 1.5 mg
0.4 ml = 2 mg
0.5 ml = 2.5 mg
The most commonly reported reactions are related to the gastrointestinal tract.
Possible side effects are highly dose-dependent and include:
- nausea, vomiting, diarrhea, constipation
- decreased appetite
- abdominal discomfort
Rarer, but more serious risks include:
- pancreatitis
- gallstones with rapid weight reduction
- hypoglycemia when combined with other antidiabetic agents
The information is collected and systematized from various scientific sources and studies. It serves solely for educational purposes and should not be used for the diagnosis, treatment, or prevention of diseases.